Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pulmonology
Volume 2014, Article ID 479025, 3 pages
http://dx.doi.org/10.1155/2014/479025
Case Report

Pulmonary Embolism following Cessation of Infliximab for Treatment of Miliary Tuberculosis

1Thomas Jefferson University, 1025 Walnut Street, Philadelphia, PA 19107, USA
2Attending, Pulmonary and Critical Care Section, Christiana Care Health System, 4745 Ogletown-Stanton Road, Map 1, Suite 220, Newark, DE 19713, USA

Received 23 June 2014; Revised 15 September 2014; Accepted 18 September 2014; Published 29 October 2014

Academic Editor: Hasan Bayram

Copyright © 2014 Brian Lee and Farid Moosavy. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Keane, S. Gershon, R. P. Wise et al., “Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent,” The New England Journal of Medicine, vol. 345, no. 15, pp. 1098–1104, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. W. G. Dixon, K. L. Hyrich, K. D. Watson et al., “Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR),” Annals of the Rheumatic Diseases, vol. 69, no. 3, pp. 522–528, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Cheng and Q. Cao, “P-030 infliximab and tuberculosis infection: a meta-analysis,” Inflammatory Bowel Diseases, vol. 19, supplement 1, p. S37, 2013. View at Publisher · View at Google Scholar
  4. K. G. Saag, G. T. Gim, N. M. Patkar et al., “American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis,” Arthritis Care and Research, vol. 59, no. 6, pp. 762–784, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Agarwal, S. K. Das, G. G. Agarwal, and R. Srivastava, “Steroids decrease prevalence of positive tuberculin skin test in rheumatoid arthritis: implications on anti-TNF therapies,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2014, Article ID 430134, 5 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. H.-Y. Sun and N. Singh, “Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients,” Current Opinion in Infectious Diseases, vol. 22, no. 4, pp. 394–402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. M. Arend, E. M. S. Leyten, W. P. J. Franken, E. M. Huisman, and J. T. van Dissel, “A patient with de novo tuberculosis during anti-tumor necrosis factor-α therapy illustrating diagnostic pitfalls and paradoxical response to treatment,” Clinical Infectious Diseases, vol. 45, no. 11, pp. 1470–1475, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. E. M. T. Salvana, G. S. Cooper, and R. A. Salata, “Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients,” Journal of Infection, vol. 55, no. 6, pp. 484–487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. G. Vidal, S. R. Fernández, J. M. Lacasa et al., “Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis,” Clinical Infectious Diseases, vol. 40, no. 5, pp. 756–759, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Kouismi, M. Laine, J.-E. Bourkadi, and G. Iraqi, “Association of deep venous thrombosis with pulmonary tuberculosis,” Egyptian Journal of Chest Diseases and Tuberculosis, vol. 62, no. 3, pp. 541–543, 2013. View at Publisher · View at Google Scholar
  11. B. C. Jha, A. Dass, N. M. Nagarkar, R. Gupta, and S. Singhal, “Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management,” Postgraduate Medical Journal, vol. 77, no. 905, pp. 185–187, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. S. C. Robson, N. W. White, I. Aronson, R. Woollgar, H. Goodman, and P. Jacobs, “Acute-phase response and the hypercoagulable state in pulmonary tuberculosis,” British Journal of Haematology, vol. 93, no. 4, pp. 943–949, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. D. W. Zahn and C. T. Peirce, “Venous thrombosis and pulmonary embolism in tuberculosis,” The American Journal of Medicine, vol. 5, no. 5, pp. 716–728, 1948. View at Publisher · View at Google Scholar · View at Scopus
  14. W.-S. Chung, C.-L. Peng, C.-L. Lin et al., “Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study,” Annals of the Rheumatic Diseases, vol. 73, pp. 1774–1780, 2014. View at Publisher · View at Google Scholar